| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.067 | 0.2 |